Articles by Michael Gold (4)

Modeling Alzheimer‘s disease progression using the disease system analysis approach

Roberto Gomeni, Monica Simeoni, Marina Zvartau- Hind, Michael C. Irizarry, Daren Austin and Michael Gold

Alzheimer`s & Dementia 8 ( 1 ): 39 - 50 , 2012

Improving Alzheimer‘s disease phase II clinical trials

Barry D. Greenberg, Maria C. Carrillo, J. Michael Ryan, Michael Gold, Kim Gallagher, Michael Grundman, Robert M. Berman, Timothy Ashwood and Eric R. Siemers

Alzheimer`s & Dementia 9 ( 1 ): 39 - 49 , 2013

Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development

Adam L. Boxer, Michael Gold, Edward Huey, Fen-Biao Gao, Edward A. Burton, Tiffany Chow, Aimee Kao, Blair R. Leavitt, Bruce Lamb, Megan Grether, David Knopman, Nigel J. Cairns, Ian R. Mackenzie, Laura Mitic, Erik D. Roberson, Daniel Van Kammen, Marc Cantillon, Kathleen Zahs, Stephen Salloway, John Morris, Gary Tong, Howard Feldman, Howard Fillit, Susan Dickinson, Zaven Khachaturian, Margaret Sutherland, Robert Farese, Bruce L. Miller and Jeffrey Cummings

Alzheimer`s & Dementia 9 ( 2 ): 176 - 188 , 2013

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)

Adam L. Boxer, Michael Gold, Edward Huey, William T. Hu, Howard Rosen, Joel Kramer, Fen-Biao Gao, Edward A. Burton, Tiffany Chow, Aimee Kao, Blair R. Leavitt, Bruce Lamb, Megan Grether, David Knopman, David Knopman, Ian R. Mackenzie, Laura Mitic, Erik D. Roberson, Daniel Van Kammen, Marc Cantillon, Kathleen Zahs, George Jackson, Stephen Salloway, John Morris, Gary Tong, Howard Feldman, Howard Fillit, Susan Dickinson, Zaven S. Khachaturian, Margaret Sutherland, Susan Abushakra, Joseph Lewcock, Robert Farese, Robert O. Kenet, Frank LaFerla, Steve Perrin, Steve Whitaker, Lawrence Honig, Marsel M. Mesulam, Brad Boeve, Murray Grossman, Bruce L. Miller and Jeffrey L. Cummings

Alzheimer`s & Dementia 9 ( 2 ): 189 - 198 , 2013